Sign in →

Test Code LAGGT Granulocyte Antibodies, Serum

Reporting Name

Granulocyte Ab, S

Useful For

Work-up of individuals having febrile, nonhemolytic transfusion reactions

 

Detection of individuals with autoimmune neutropenia

 

This test is not useful for the diagnosis of neutropenia caused by marrow suppression by drugs or tumors.

Method Name

Indirect Immunofluorescence

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Specimen Type

Serum Red


Specimen Required


Collection Container/Tube: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 1.5 mL

Collection Instructions: Centrifuge and aliquot serum into a plastic vial.

Additional Information: Only pretransfusion reaction specimen is acceptable.


Specimen Minimum Volume

0.3 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Red Refrigerated (preferred) 30 days
  Frozen  365 days
  Ambient  7 days

Reject Due To

Gross hemolysis OK
Gross lipemia OK
Gross icterus OK

Reference Values

Not applicable

Day(s) Performed

Tuesday, Wednesday, Friday

CPT Code Information

86021

LOINC Code Information

Test ID Test Order Name Order LOINC Value
LAGGT Granulocyte Ab, S 35279-9

 

Result ID Test Result Name Result LOINC Value
LAGG Granulocyte Ab, S 35279-9

Clinical Information

Granulocyte antibodies are induced by pregnancy or prior transfusion and are associated with febrile, nonhemolytic transfusion reactions. Patients who have been immunized by previous transfusions, pregnancies, or allografts frequently experience febrile, nonhemolytic transfusion reactions that must be distinguished from hemolysis before further transfusions can be safely administered. Granulocyte antibodies may also be present in autoimmune neutropenia.

Interpretation

A positive result in an individual being worked up for a febrile transfusion reaction indicates the need for leukocyte-poor (filtered) red blood cells.

 

This test cannot distinguish between allo- and autoantibodies

Cautions

No significant cautionary statements

Method Description

Purified granulocyte preparations from normal donors are incubated with patient's test serum and then with fluorescein-tagged antihuman globulin reagent. Sera containing the antibodies deposit immunoglobulin on the target cell membrane, which is detected by the second stage antibody and visualized by fluorescence microscopy.(Verheugt FW, von dem Borne AE, Decary F, Engelfreit CP. The detection of granulocyte alloantibodies with an indirect immunofluorescence test. Br J Haematol. 1997;36(4):533-534)

Report Available

7 to 15 days

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.